AbbVie Net Change in Cash increased by 52.3% to -$400.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 76.9%, from -$1.73B to -$400.00M. Over 2 years (FY 2022 to FY 2025), Net Change in Cash shows an upward trend with a -26.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
cf_net_change_in_cash| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.21B | $3.64B | -$3.65B | $2.42B | $3.31B | -$2.63B | -$2.49B | $2.05B | $4.53B | $5.25B | -$4.94B | -$5.87B | -$1.73B | -$349.00M | $1.29B | -$838.00M | -$400.00M |
| QoQ Change | — | +400.7% | -200.3% | +166.4% | +36.6% | -179.5% | +5.4% | +182.2% | +121.1% | +16.0% | -194.0% | -19.0% | +70.5% | +79.9% | +470.2% | -164.9% | +52.3% |
| YoY Change | — | — | — | +300.4% | -8.9% | — | +31.7% | -15.5% | +36.8% | +311.0% | -341.1% | -229.7% | — | -106.6% | +126.2% | +85.7% | +76.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.